BMCC Newsletter Issue #424 - Healthcare Edition #2 (30 September 2024)
|
|
This edition of our Healthcare Edition of the newsletter, an initiative supported by our Healthcare Committee, contains the following highlights: - Ministry of Health Malaysia Hosts MIH Megatrends and is Calling for Exhibitors
- RSVP to our events on Private Healthcare and Mental Health Advocacy
- Urgent Reminder from the Malaysian Ministry of Immigration
- Enjoy an Exclusive Comprehensive Health Screening as a BMCC Member
|
|
Malaysian Ministry of Health Hosts Malaysia International Healthcare Megatrends 2024 Calls for Exhibitors to Showcase Healthcare Technologies |
|
Dear Subscriber,
In Malaysia's journey to enhance healthcare accessibility, the Malaysian Ministry of Health (MOH), in collaboration with our member, KPJ Healthcare and in strategic partnership with the Malaysian Communications and Multimedia Commission (MCMC) will be organising the nation's premier healthcare event: Malaysia International Healthcare (MIH) Megatrends 2024.
Happening from 25 to 27 October 2024, MIH Megatrends is set to bring together global healthcare leaders, professionals, innovators, and policymakers to explore groundbreaking advancements, exchange knowledge and forge partnerships aimed at elevating the quality, accessibility, and sustainability of healthcare.
The Department for Business and Trade Malaysia (DBT) a supporting partner of MIH, invites BMCC Members in the digital health sector to showcase their cutting-edge technologies designed to help healthcare needs. They have also negotiated special discounts for booths at the event, making it an opportunity you won't want to miss!
|
|
Date: 25 to 27 October 2024 Venue: Kuala Lumpur Convention Centre
For more information, visit them here. |
|
Are you a BMCC Member and in the Healthcare Industry?
|
|
| Bridging Borders: Exploring Malaysia's Private Healthcare |
|
|
|
Achieve excellence by making mental health a priority in your workplace or learning environment.
Learn expert insights from our speakers and exchange best practices with a network of seasoned academics.
Date: 16 October 2024 Time: 3:00 pm to 5:00 pm Venue: British Council Malaysia
Target Audience: Mid-level and above representatives from academic and operations functions of higher education institutions from BMCC members; representatives from relevant private and Government stakeholders |
|
| Mental Health Advocacy for the Workplace and Learning Environment |
|
|
|
Healthcare is a universal concern that impacts all lives.
That is why BeLuxCham is organising an enlightening inter-chamber healthcare session that will reveal the dynamic landscape of Malaysia's private healthcare sector.
Access insights from professional consultants in the medical field and discover new roads to better living.
Date: 3 October 2024 Time: 9:30 am to 12:00 pm Venue: Auditorium, Prince Court (L1) |
|
| Medizee | Enjoy an Exclusive Comprehensive Health Screening as a BMCC Member |
|
|
|
Medizee is offering an exclusive price to BMCC members for a comprehensive health screening for both males and females for under RM250 and RM48 only for a basic health screening.
The comprehensive health screening comes with additional benefits such as 10% discount vouchers on supplements, free shopping bags, and more.
Medizee also provides pre-employment health screening as well as on-site services such as nutrition and health talks with corporate members.
|
|
| Immigration Department of Malaysia | Reminder to Complete and Resubmit Returned Applications |
|
|
|
Effective 1 October 2024, any returned applications that remain unsubmitted at the company's returned application inbox for over 90 days will be automatically cancelled by the ESD Online. |
|
|
Please be aware that the processing fee for these cancelled dormant applications will be forfeited and is non-refundable.
However, there are a few exceptions to consider. Please review the following situations: - Upon feature implementation, all applications returned on or before 30 April 2024 that remain unsubmitted will be automatically cancelled.
- For applications returned on or after 1 May 2024, you are encouraged to complete and resubmit them if you wish to continue with your application. If these applications remain unsubmitted by 1 January 2025, they will be automatically cancelled.
- If returned applications are automatically cancelled due to pending documents and a longer time required to provide them, please email a justification to our helpdesk for deliberation.
This message is a reminder to review and complete your returned applications.
For further inquiries or clarification, please email helpdesk@myxpats.com.my or contact the MYXpats Helpdesk at 03-7839 7171. |
|
| MOH Mandates Two Suppliers In Off-Patent Drugs, Medical Devices Procurement |
|
|
|
Deputy Sec-Gen (Finance) Norazman Ayob says the Ministry of Health (MOH) now requires two suppliers in certain procurement tenders for off-patent drugs and medical devices to boost medicine security, besides seeking the right to renegotiate contracts if there’s a cheaper supplier.
|
|
|
| Sunway Medical Centre Damansara Bound for Q4 launch |
|
|
|
Sunway Healthcare Group’s new hospital in Kota Damansara is set to open in the fourth quarter (Q4) of the year.
With over 250 beds, the upcoming Sunway Medical Centre Damansara will be the fourth comprehensive tertiary hospital of the group.
|
|
|
| Sunway Medical Centre Celebrates 25 Years with Health Carnival |
|
|
|
Sunway Medical Centre (SMC), kicked off its 25th anniversary celebrations with the annual SunMed Health Carnival on 8 September, drawing a large crowd to the iconic Tower D Lobby.
Read the full article here. |
|
|
| Sunway Medical Centre Launches CSR Radiotherapy And Educational Forum On Innovative Cancer Treatment In Sarawak |
|
|
|
Sunway Medical Centre (SMC) recently launched its Corporate Social Responsibility (CSR) Radiotherapy Programme and hosted a public health forum entitled “Fearless Against Cancer: Innovations in Cancer Treatment” in Kuching, Sarawak.
Read the full article here. |
|
|
| Sunway Medical Centre Earns Prestigious JCI Accreditation |
|
|
|
Congratulations to Sunway Medical Centre on recently achieving the globally recognised Joint Commission International (JCI) Accreditation.
Discover how Sunway Medical Centre’s JCI Accreditation sets a new standard in Malaysian healthcare, ensuring top-tier patient care and safety here. |
|
|
| GSK's Arexvy Vaccine for RSV Approved in Malaysia |
|
|
|
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) announced that the Arexvy vaccine (MAL20486007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). |
|
|
RSV is a common respiratory virus that can lead to serious negative clinical outcomes, such as lower respiratory tract disease (LRTD) and pneumonia in older adults.
"At GSK, we believe that prevention is the most beneficial intervention that we can have for patients and healthcare systems... For the RSV vaccine, with our joint effort, has the potential to not only improve the life of the patient but also prevent a lot of suffering and save lives," - Ruxandra Nastasa, Vice President and General Manager of GSK Malaysia and Brunei
Read the full article here. |
|
| GSK Ready to Work with UK Government on Innovation |
|
|
|
GSK plc’s chief executive officer said the UK drugmaker is ready to partner with the new Labour government on research and development (R&D) as it seeks to boost Britain’s standing as an innovation hub.
Read the full article here. |
|
|
| GSK | Shingles Vaccine Now Available in Malaysia |
|
|
|
On September 10, GSK announced the launch of its Herpes Zoster vaccine, Shingrix, also known as Recombinant Zoster Vaccine, Adjuvanted (RZV) in Malaysia for the prevention of shingles (herpes zoster, HZ) and post-herpetic neuralgia (PHN) in adults aged 50 years and over. |
|
|
RZV is a non-live, recombinant subunit adjuvanted vaccine given intramuscularly in two doses.
RZV will initially be available in Malaysia to adults aged 50 and over and those aged 18 and over who are at increased risk of HZ.
Read the full article here. |
|
| AstraZeneca Collaborates with Lung Cancer Network Malaysia to Successfully Treat Lung Cancer using AI |
|
|
|
Lung Cancer Network Malaysia (LCNM), in collaboration with AstraZeneca Malaysia, have announced the successful diagnosis and treatment of Malaysia’s first lung cancer case detected using artificial intelligence (AI).
This landmark achievement underscores the potential of AI in revolutionising healthcare, particularly in early cancer detection.
Vinod Narayanan, Country President of AstraZeneca Malaysia and member of our Board of Directors, said, “By leveraging AI-enhanced chest X-rays (AI-CXRs) and low-dose computed tomography (LDCT) scans, we aim to make lung cancer screening more accessible and cost-effective.
Read the full article here. |
|
|
| Pantai Hospital Kuala Lumpur Introduces Outpatient Parenteral Antimicrobial Therapy (OPAT) for Improved Patient Care |
|
|
|
Pantai Hospital Kuala Lumpur (PHKL) has officially introduced its Outpatient Parenteral Antimicrobial Therapy (OPAT) service, offering an innovative treatment option that enhances patient care.
Read the full article here. |
|
|
| PwC Malaysia Corporate Finance Team Advised Employee Healthcare Benefits Management Platform |
|
|
|
On 15 August, the PwC Malaysia Corporate Finance team is pleased to announce the ~RM 40m Series B fundraising of a leading employee healthcare benefits management platform in Malaysia (“Issuer”) via issuance of minority equity stake to 2 venture capital firms (“Investor”)
PwC Malaysia Corporate Finance team acted as financial advisors to the Issuer in connection with the transaction.
|
|
|
| UM’s Medical Faculty Targets 200 Graduates Annually Despite Declining Interest In Medicine |
|
|
|
Universiti Malaya’s (UM) Faculty of Medicine aims to produce up to 200 medical graduates annually, doubling its 1962 target when the faculty was established in Kuala Lumpur.
Dean Prof Dr Yang Faridah Abdul Aziz said that despite waning interest in the field of medicine, UM’s medical faculty remains a top choice for aspiring doctors. |
|
|
“Being a premier university, I know a lot has been said about medicine and the declining interest in medical studies, but at the Faculty of Medicine, because we continue to push forward the vision and mission of nurturing lives and empowering communities through high-quality health care, scholarship, education and research, we still remain, and I’m very grateful for that, we still remain the choice for the next generation of doctors,”
Read the full article here. |
|
| KPJ Healthcare Unveils New Brand Identity, Signifying New Chapter |
|
|
|
Our member, KPJ Healthcare Berhad, has unveiled its new brand identity, intensifying its push for patient-centricity as a foundation for exponential growth and competitive edge in the dynamically evolving healthcare landscape.
“The rebranding is a symbol of KPJ’s transformation and progress as we accelerate our efforts to deliver an improved experience driven by technology and innovation. The rebranding exercise goes hand-in-hand with the enhancement of our service delivery to all stakeholders” – Chin Keat Chyuan, President and Managing Director of KPJ Healthcare.
Read the full article here. |
|
|
| KPJ Damansara Launches Malaysia’s First Dengue Vaccine |
|
|
|
The dengue vaccine is now available at KPJ Damansara Specialist Hospital: RM400 for 2 doses, given 3 months apart. Dr Musa Nordin urges all eligible persons above 4 years old to consider taking the dengue vaccine that cuts the risk of hospitalisation by 84%.
Read the full article here. |
|
|
| KPJ Healthcare Aims Big in Health Tourism |
|
|
|
President and managing director Chin Keat Chyuan said the company’s health tourism business grew by 41% last year.
Read the full article here. |
|
|
| N.J. Akers & Co | Healthcare IP Services |
|
|
|
Entering the healthcare market in the UK with new or improved technology can be problematic. Accessing the National Health Service (NHS) is key, as the single largest provider of healthcare services in the UK. |
|
|
Protecting new innovations, brands and designs is also important if competition from other companies is to be avoided. Avoiding infringement of the IP rights of other companies is also essential, if full market penetration is to be achieved. N.J. Akers & Co. is a law firm specialising in intellectual property (IP) law, with a particular focus on Healthcare and healthcare-related technology. The firm advises and assists clients in the procurement and enforcement of IP rights, including patents, trade marks and designs, in the UK, Europe and worldwide via its network of associate law firms. The firm assists clients with other matters, including asserting rights against infringers, advising regarding infringement of third party rights, licensing of IP rights and acquisition or divestiture of IP rights. N.J. Akers & Co. assists and represents a significant number of NHS Trusts in the UK. NHS Trusts are potentially very valuable partners in developing new healthcare technology and entering the UK market, providing opportunities to access relevant clinical data, as well as develop and test new products and services for the UK market. N.J. Akers & Co. can introduce companies wishing to develop new technology as possible partners to the appropriate Trust.
Read more about them by visiting their site here. |
|
Share Your Insights We want to showcase how you are making a positive impact in the healthcare industry in our future editions!
Share with our team how your organisation is bringing the British and Malaysian healthcare industry to new heights. |
|
Stay up to date with the Chamber’s latest news and activities through this newsletter or follow us on our social media platforms. |
|
British Malaysian Chamber of Commerce Berhad 201801018075 (1280091-P) No 02-B, Menara IQ, Lingkaran TRX, Tun Razak Exchange, 55188 Kuala Lumpur Copyright © BMCC 2024 |
|
|
